Recently, the 2025CPHI Southeast Asia Exhibition was held in Malaysia. Nanjing King-Friend Biochemical Pharmaceutical Co., LTD. (hereinafter referred to as " NKF ")was invited to participate and comprehensively showcased the company's strong capabilities in new drug research and development, formulation production and other aspects.

CPHI Southeast Asia Exhibition is a highly influential pharmaceutical event in the local area. NKF took advantage of this international platform to introduce its innovative drugs and generic drugs, as well as its advanced quality control system, through multi-faceted explanations and other forms.

At the exhibition, the NKF business team actively engaged in exchanges with nearly 40 companies, jointly exploring cooperation, innovation and sustainable solutions, establishing partnerships and creating greater value together.

Through this participation in the exhibition, NKF has further enhanced its brand awareness and also opened up new channels for the company to penetrate the Southeast Asian and even global markets.